SPSS Data set persons with diabetes. by Joseph Ngmenesegre Suglo (9553147)

“…</p><p>Conclusion</p><p>A contextual family-oriented foot self-care education intervention is feasible, acceptable, and may improve knowledge and self-care with the potential to decrease diabetes-related complications. …”

Feasibility outcomes. by Joseph Ngmenesegre Suglo (9553147)

“…</p><p>Conclusion</p><p>A contextual family-oriented foot self-care education intervention is feasible, acceptable, and may improve knowledge and self-care with the potential to decrease diabetes-related complications. …”

Participant eligibility criteria. by Joseph Ngmenesegre Suglo (9553147)

“…</p><p>Conclusion</p><p>A contextual family-oriented foot self-care education intervention is feasible, acceptable, and may improve knowledge and self-care with the potential to decrease diabetes-related complications. …”

Predefined feasibility criteria. by Joseph Ngmenesegre Suglo (9553147)

“…</p><p>Conclusion</p><p>A contextual family-oriented foot self-care education intervention is feasible, acceptable, and may improve knowledge and self-care with the potential to decrease diabetes-related complications. …”

Demographic characteristics of participants. by Joseph Ngmenesegre Suglo (9553147)

“…</p><p>Conclusion</p><p>A contextual family-oriented foot self-care education intervention is feasible, acceptable, and may improve knowledge and self-care with the potential to decrease diabetes-related complications. …”

CONSORT flow diagram. by Joseph Ngmenesegre Suglo (9553147)

“…</p><p>Conclusion</p><p>A contextual family-oriented foot self-care education intervention is feasible, acceptable, and may improve knowledge and self-care with the potential to decrease diabetes-related complications. …”

Original and modified version of intervention. by Joseph Ngmenesegre Suglo (9553147)

“…</p><p>Conclusion</p><p>A contextual family-oriented foot self-care education intervention is feasible, acceptable, and may improve knowledge and self-care with the potential to decrease diabetes-related complications. …”

EGC inhibits breast cancer growth and LDH-A expression <i>in vivo</i>. by Zhiyu Wang (282312)

“…The results showed that in both breast cancer xenografts, the expression levels of LDH-A, Ki67 and HIF-1α were decreased in comparison to that in control groups, while apoptosis ratio was elevated in EGC-treated tumor samples detected by TUNEL method; (C) Western blotting analysis showed that the expression of HIF-1α and LDH-A in EGC-treated tumor samples were significantly decreased in comparison with control groups (left panel). …”

Mitochondrial Dysfunction in Human Leukemic Stem/Progenitor Cells upon Loss of RAC2 by Marta E. Capala (652765)

“…Downregulation of SAM50 also impaired the proliferation and replating capacity of BCR-ABL-expressing cells, again associated with a decreased mitochondrial membrane potential. …”

Effects of A1AR expression on response to hypoxia at E9.5 and E12.5. by Daniela L. Buscariollo (140729)

“…<p>A: At E9.5, responses to hypoxia in A1AR −/− (n = 15) and A1AR +/− (n = 50) embryos were studied. …”

S13 Fig - by Gamalat A. Elgedawy (18700038)

Performance of selected antimalarials against field isolates during the study period. by Winnie Okore (14139712)

Primers used for analysis of four SNPs in one gene. by Winnie Okore (14139712)

Diagram illustrating thalamic network model and its cortical inputs. by Austin E. Soplata (4676017)

Canonical T7SS substrate EsxA is conserved across GBS T7SS subtypes I—III. by Brady L. Spencer (7294382)

<i>In vivo</i> dynamic near-infrared fluorescent imaging of A-431 tumor models. by Lingbo Zhang (132359)

“…On day 4, 8, 12 (after As₂O₃ treatment), the signal intensity of EGF-Cy5.5 uptake by control group (0 mg/kg/day As₂O₃) gradually increased, while the intensities in other three groups with different concentrations (0.5 mg/kg/day, 2.5 mg/kg/day, 5.0 mg/kg/day) of As₂O₃ treatment gradually decreased (<i>p</i><0.05). …”

Estimation of A3G and Vif production rates. by Iraj Hosseini (184245)

“…All the results in (A) and (B) are obtained for <i>k_A3G.HIV</i> = 50 µM⁻¹/hr. …”

Number of samples per site during the study period. by Winnie Okore (14139712)

Performance of selected drugs against field isolates during the study period. by Winnie Okore (14139712)

<i>In vitro</i> susceptibility responses of field isolates to antimalarials during the study period. by Winnie Okore (14139712)